<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To establish whether Barrett's surveillance is worthwhile in terms of incident <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> and whether outcomes are favourable </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A prospective non-randomized single centre Barrett's surveillance programme commencing 1 January 1992 through 1 April 2001 (112 months) </plain></SENT>
<SENT sid="2" pm="."><plain>Oesophagectomy recommended for high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of 23 725 patients, 506 were diagnosed as <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and 24 (5%) had <z:mp ids='MP_0002038'>carcinoma</z:mp> at diagnosis (prevalence <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred and twenty-six patients had at least one surveillance endoscopy; 248 surveillance endoscopies were performed spanning 338 patient years </plain></SENT>
<SENT sid="5" pm="."><plain>Thirteen surveillance (incidence) <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were detected </plain></SENT>
<SENT sid="6" pm="."><plain>In the prevalence <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group 12 of the 24 patients underwent oesophagectomy </plain></SENT>
<SENT sid="7" pm="."><plain>Lymph nodes showed evidence of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in 10 of the 12 resections </plain></SENT>
<SENT sid="8" pm="."><plain>In the surveillance group 10 patients underwent oesophagectomy </plain></SENT>
<SENT sid="9" pm="."><plain>Lymph nodes showed evidence of <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> in one of the 10 resections </plain></SENT>
<SENT sid="10" pm="."><plain>One patient in the prevalence <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group (4% of group; 8% of those operated) and seven patients in the surveillance <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> group (54% of group; 70% of those operated) remain disease-free more than 2 years post-oesophagectomy </plain></SENT>
<SENT sid="11" pm="."><plain>The cost per <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cured is 7546 pounds </plain></SENT>
<SENT sid="12" pm="."><plain>One curable <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was detected per 48 patient years of surveillance </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Few Barrett's surveillance studies have addressed treatment outcomes and survival </plain></SENT>
<SENT sid="14" pm="."><plain>In our study 5% of Barrett's patients undergoing endoscopy have prevalent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="15" pm="."><plain>If surveillance is performed, 4% per year develop <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and 2% per year are cured of their <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="16" pm="."><plain>Most surveillance <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are operable and of those undergoing surgery 70% are cured </plain></SENT>
<SENT sid="17" pm="."><plain>Barrett's surveillance is cost-effective compared with other <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> screening or surveillance initiatives </plain></SENT>
</text></document>